Literature DB >> 15731994

Acute hepatitis C: a multifaceted disease.

Theo Heller1, Barbara Rehermann.   

Abstract

Although acute hepatitis C virus (HCV) infection is a rare disease and typically not associated with severe clinical symptoms, it has become a disease of significant interest for clinical investigators, virologists, and immunologists alike. In the same way that acute hepatitis C provided a window of opportunity for understanding the clinical and virological aspects of HCV infection as the field was being established, it is now clear that it can provide a window into further understanding the early interaction of the virus with the host immune response. The acute phase of infection is usually considered to be the first 6 months; however, rather than defining acute HCV by the time that has passed after initial infection, it can also be defined as the biological state in which spontaneous clearance is still possible.

Entities:  

Mesh:

Year:  2005        PMID: 15731994     DOI: 10.1055/s-2005-864778

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  25 in total

1.  Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance.

Authors:  Rachel E Gicquelais; Betsy Foxman; Joseph Coyle; Marisa C Eisenberg
Journal:  Epidemics       Date:  2019-02-28       Impact factor: 4.396

Review 2.  Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.

Authors:  Emma Kaplan-Lewis; Daniel Seth Fierer
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 3.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

Review 4.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 5.  Current progress in development of hepatitis C virus vaccines.

Authors:  T Jake Liang
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

6.  Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.

Authors:  Sukanya Raghuraman; Heiyoung Park; William O Osburn; Emily Winkelstein; Brian R Edlin; Barbara Rehermann
Journal:  J Infect Dis       Date:  2012-01-31       Impact factor: 5.226

7.  Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.

Authors:  Lia L Lewis-Ximenez; Georg M Lauer; Julian Schulze Zur Wiesch; Paulo Sergio Fonseca de Sousa; Cleber F Ginuino; Gláucia Paranhos-Baccalá; Hanno Ulmer; Karl P Pfeiffer; Georg Goebel; João Luiz Pereira; Jaqueline Mendes de Oliveira; Clara Fumiko Tachibana Yoshida; Elisabeth Lampe; Carlos Eduardo Velloso; Marcelo Alves Pinto; Henrique Sergio Coelho; Adilson José Almeida; Carlos Augusto Fernandes; Arthur Y Kim; Alexander M Strasak
Journal:  Clin Infect Dis       Date:  2010-05-01       Impact factor: 9.079

8.  Acute hepatitis C: prospects and challenges.

Authors:  Sanaa M Kamal
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

9.  Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.

Authors:  Daniel S Fierer; Alison J Uriel; Damaris C Carriero; Arielle Klepper; Douglas T Dieterich; Michael P Mullen; Swan N Thung; M Isabel Fiel; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

10.  Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.

Authors:  Jorge Monserrat; Raul de Pablo; Eduardo Reyes; David Díaz; Hugo Barcenilla; Manuel R Zapata; Antonio De la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Crit Care       Date:  2009-02-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.